The relationship between B7 homologous 1 with interleukin-4, interleukin-17 and interferon gamma in patients with allergic rhinitis
Authors:
- 22 July 2019
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 15 (8) , 897-901
Abstract
Background: Allergic rhinitis is the most common atopic disorder and the most common chronic allergic disease. The etiology of this disease includes an increase in cytokine levels, including IL- 4, IL- 13, IL- 17, and reduction in B7 homologous 1 (B7-H1) or programmed cell death-1 ligand-1 (PD-L1), a new member of the CD28: B7 stimulant molecule family. The aim of this study was to determine the relationship between cytokines and PD-L1. Methods: In this experimental study, 80 patients with allergic rhinitis were enrolled according to inclusion and exclusion criteria. The severity and stage of the disease were determined by a specialist physician. A 5 cc venous blood sample was collected from the patients. IL-4, IL-17, INFγ and PD-L1 were measured using ELISA technique. The statistical analysis was performed using the SPSS15 software and correlation between levels of interleukins and PD-L1 and interferon gamma molecules was assessed using PERMANOVA test. Results: The mean age of the subject was 28.5±1.3 years. Out of the 80 subjects, 46 (57.5%) were male. There was a significant correlation between SPD-L1 and INFγ, IL-4 and IL-17 in allergic rhinitis patients (P <0.05). Statistical analysis based on the severity of the disease (Mild, Moderate and Severe) showed a significant positive correlation between the SPD-L1 and INFγ in all three levels (P <0.001). There was also a significant negative correlation between SPD-L1 and two cytokines IL-4 and IL-17 (P <0.001). In regard to the duration of the disease (persistent or intermittent), a significant positive correlation was found between SPD-L1 and INFγ in both groups (P <0.001). Conclusion: Considering the negative correlation between the PD-L1 molecule and the levels of IL-4 and IL-17 as inflammatory cytokines, PD-L1 may have a protective role against allergic rhinitis, although the precise mechanism requires further detailed studies.Keywords
Funding Information
- Kurdistan University Of Medical Sciences (No 1396.95)
This publication has 18 references indexed in Scilit:
- Peripheral Th17/Treg cell-mediated immunity imbalance in allergic rhinitis patients ,Brazilian Journal of Otorhinolaryngology, 2014
- Emerging role of interleukin-22 in autoimmune diseasesCytokine & Growth Factor Reviews, 2013
- PD-1 Regulates the Growth of Human Mastocytosis CellsAllergology International, 2013
- Allergic rhinitis and its associated co-morbidities at Bugando Medical Centre in Northwestern Tanzania; A prospective review of 190 casesBMC Ear, Nose and Throat Disorders, 2012
- Targeting Interleukin-4 in Asthma: Lost in Translation?American Journal of Respiratory Cell and Molecular Biology, 2012
- Cytosine–phosphate–guanosine-DNA induces CD274 expression in human B cells and suppresses T helper type 2 cytokine production in pollen antigen-stimulated CD4-positive cellsClinical and Experimental Immunology, 2012
- Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell linesCytokine, 2011
- B7-H1 (PD-L1) on T cells is required for T-cell-mediated conditioning of dendritic cell maturationProceedings of the National Academy of Sciences, 2009
- Pediatric allergic rhinitis: Physical and mental complicationsAllergy and Asthma Proceedings, 2008
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005